Recurrent Large Cell Lung Carcinoma Active Not Recruiting Phase 3 Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0044224 (Recurrent Large Cell Lung Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00946712S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung CancerTreatment